- Regulus to Accelerate Development of RG-101 as Backbone Therapy in HCV - LA JOLLA, Calif., Feb. 17, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback